← Back to Search

Behavioral Intervention

Digital Intervention for HIV/STI Testing in Black Women

N/A
Recruiting
Led By Liesl A Nydegger, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline assessment prior to intervention beginning
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will test a new way to get more black women in the South to test for HIV at home, which could lead to earlier treatment and prevention.

Who is the study for?
This trial is for Black women aged 15-59 living in Travis County who haven't tested for HIV/STIs in the past year, had unprotected sex during that time, and can use a smartphone with internet. It's not open to those outside this age range or location, who've been recently tested, always used protection, or lack English fluency.Check my eligibility
What is being tested?
The study tests a web-based intervention aimed at increasing home testing for HIV among Black women at risk. The program encourages self-testing and connects participants to healthcare services and PrEP evaluation to prevent HIV infection.See study design
What are the potential side effects?
Since this is a digital intervention promoting home testing without direct medical treatment involved, there are no traditional side effects like you'd expect from medication. However, users may experience stress or anxiety related to self-testing.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline assessment prior to intervention beginning
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline assessment prior to intervention beginning for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attended PrEP evaluation
Checked HIV results
Mailed HIV test
+2 more
Secondary outcome measures
Acceptability
Checked STI results
Feasibility
+3 more
Other outcome measures
Clear instructions
Demographic eligibility
Measures appropriate and no errors
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Educational ControlExperimental Treatment1 Intervention
Participants will receive the HIV/STI home testing kit, instructions to mail in the kit, notification when their results are ready to check online, treatment from a provider at Kind Clinic for positive results, and referral to Kind Clinic for PrEP. Participants will receive a web-based standard of care via a combination of videos, audio, and text/graphics across 5 sessions. Each session and assessment will occur every 3 days. Session 1: Basic information about STIs. Session 2: HIV and stigma, basic information about HIV, and HIV transmission facts and myths. Session 3: Four stories about different people who are HIV-positive, how they contracted HIV, and one story about a woman who contracted herpes and how they all cope and live healthy lives. Session 4: How to tell someone you have an STI. Session 5: Basic information about PrEP, and information on how to correctly use a male condom, female condom, and dental dam.

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
345 Previous Clinical Trials
79,452 Total Patients Enrolled
Liesl A Nydegger, PhDPrincipal InvestigatorUniversity of Texas at Austin

Media Library

Empowered to Test Yourself (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05390541 — N/A
Sexually Transmitted Infections Research Study Groups: Educational Control
Empowered to Test Yourself (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05390541 — N/A
Sexually Transmitted Infections Clinical Trial 2023: Empowered to Test Yourself Highlights & Side Effects. Trial Name: NCT05390541 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age restriction for participation in this clinical trial?

"This trial seeks volunteers who are between 15 and 59 years old."

Answered by AI

Is my eligibility sufficient to partake in this experiment?

"This scientific research is enrolling 90 participants aged 15 to 59, who have contracted a sexually transmitted disease. Criteria for inclusion encompass being between the age bracket of likely HIV contraction (15-59), identifying as cis-gender female and Black/African American (including mixed race/ethnicity) , having English proficiency, not taking an HIV or STI test in the past 12 months, living in Travis County with recent unprotected sexual contact and access to both technology and internet."

Answered by AI

How many participants have been recruited to participate in this medical experiment?

"Affirmative. The trial, which was initially posted on February 2nd 2022 is currently recruiting patients as seen in the clinicaltrials.gov database entry that was last updated on May 19th 2022. To date, 90 participants need to be sourced from 1 healthcare facility."

Answered by AI

Is this investigation actively searching for participants?

"According to the clinicaltrials.gov listing, this trial is in need of participants as it was first launched on February 2nd 2022 and revised most recently on May 19th 2022."

Answered by AI

What is the principal aim of this experiment?

"The primary goal of this trial is to determine the effectiveness of Prep Evaluation. Secondary objectives include determining whether participants mailed their STI tests, received necessary treatment for any positive results, and if they actually made use of the provided home test kits. These outcomes will be tracked within two days after mailing out HIV home testing materials."

Answered by AI
~4 spots leftby Mar 2024